<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02837705</url>
  </required_header>
  <id_info>
    <org_study_id>2015-0514</org_study_id>
    <nct_id>NCT02837705</nct_id>
  </id_info>
  <brief_title>Therapeutic Antibodies Against Prion Diseases From PRNP Mutation Carriers</brief_title>
  <acronym>PRNP</acronym>
  <official_title>Therapeutic Antibodies Against Prion Diseases From PRNP Mutation Carriers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <brief_summary>
    <textblock>
      The human Prion diseases can be classified into sporadic, acquired and inherited forms.
      Inherited forms usually manifest in higher age so there have to be factors preventing Prion
      propagation in young mutation carriers. Antibodies against the flexible tail of Prions have
      been shown to be protective in mice. The investigators intend to screen mutation carriers and
      controls for the presence of Prion autoantibodies.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>Anti-Prion protein autoantibody levels</measure>
    <time_frame>Baseline, up to 90 years</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Prion Diseases</condition>
  <arm_group>
    <arm_group_label>carriers of a mutation in the Prion gene</arm_group_label>
    <description>Carriers of a mutation in the Prion gene who are either symptomatic or pre-symptomatic and who do either know or not know their mutation status.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>family members of carriers of a mutation in the Prion gene</arm_group_label>
    <description>Relatives of confirmed PrP mutation carriers who carry two wild type alleles.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>blood draw</intervention_name>
    <arm_group_label>carriers of a mutation in the Prion gene</arm_group_label>
    <arm_group_label>family members of carriers of a mutation in the Prion gene</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Male or female carriers of a mutation in the Prion protein gene of any age and their wild
        type siblings.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Relatives of patients of genetic Prion diseases

          -  Obtained informed consent

        Exclusion Criteria:

          -  No informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Adriano Aguzzi, MD, PhD</last_name>
    <email>adriano.aguzzi@usz.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Karl Frontzek, MD</last_name>
    <email>karl.frontzek@usz.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UCSF Memory and Aging Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Geschwind</last_name>
      <email>cjdstudies@memory.ucsf.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical University Graz</name>
      <address>
        <city>Graz</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ewald Lindner</last_name>
      <email>ewald.lindner@medunigraz.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Medical Center Göttingen</name>
      <address>
        <city>Göttingen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Inga Zerr</last_name>
      <email>IngaZerr@med.uni-goettingen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CJD Foundation Israel</name>
      <address>
        <city>Pardés H̱anna Karkur</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alice Anane</last_name>
      <email>alice@Dido.co.il</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Istituto di Ricerche Farmacologiche</name>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gianluigi Forloni</last_name>
      <email>forloni@marionegri.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Slovak Medical University</name>
      <address>
        <city>Bratislava</city>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dana Zakova</last_name>
      <email>dana.slivarichova@szu.sk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institute of Neuropathology</name>
      <address>
        <city>Zürich</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adriano Aguzzi, MD, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Germany</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Slovakia</country>
    <country>Switzerland</country>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 7, 2016</study_first_submitted>
  <study_first_submitted_qc>July 14, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 20, 2016</study_first_posted>
  <last_update_submitted>November 9, 2017</last_update_submitted>
  <last_update_submitted_qc>November 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prion Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antibodies</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

